Simian Immunodeficiency Virus-Specific CD8+ T Cells Recognize Vpr- and Rev-Derived Epitopes Early after Infection |
| |
Authors: | Jonah B Sacha Matthew B Buechler Laura P Newman Jason Reed Lyle T Wallace John T Loffredo Nancy A Wilson David I Watkins |
| |
Institution: | Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin 53715 |
| |
Abstract: | The kinetics of CD8+ T cell epitope presentation contribute to the antiviral efficacy of these cells yet remain poorly defined. Here, we demonstrate presentation of virion-derived Vpr peptide epitopes early after viral penetration and prior to presentation of Vif-derived epitopes, which required de novo Vif synthesis. Two Rev epitopes exhibited differential presentation kinetics, with one Rev epitope presented within 1 h of infection. We also demonstrate that cytolytic activity mirrors the recognition kinetics of infected cells. These studies show for the first time that Vpr- and Rev-specific CD8+ T cells recognize and kill simian immunodeficiency virus (SIV)-infected CD4+ T cells early after SIV infection.The antiviral activity of AIDS virus-specific CD8+ T cells is well documented in both in vivo (1, 4, 21) and in vitro (8, 24, 29) studies. Accordingly, human immunodeficiency virus (HIV) vaccine modalities that focus on engendering antiviral CD8+ T cells are being developed (13, 26, 28). Ideally, a CD8+ T cell-based vaccine would stimulate responses against epitopes that are presented by major histocompatibility complex class I (MHC-I) molecules early after infection of a target cell. However, successful selection of antigenic sequences for a CD8+ T cell-based vaccine has been frustrated in part by an incomplete understanding of the properties of effective CD8+ T cell responses (25). |
| |
Keywords: | |
|
|